ORAGENICS, INC. Proceeds from Securities Purchased under Agreements to Resell
ORAGENICS, INC. (OGEN) reported Proceeds from Securities Purchased under Agreements to Resell of $1.00 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromSecuritiesPurchasedUnderAgreementsToResell · last filed 2012-08-10
- 2012-06-30: Proceeds from Securities Purchased under Agreements to Resell 6 month $1.00M.
| Period end | Proceeds from Securities Purchased under Agreements to Resell 6 month |
|---|---|
| 2012-06-30 | $1.00M 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |